title: Triple whammy. Will an AIDS therapy live up to its advance billing?
authors.forename: J
authors.initials: J
authors.lastname: Rennie
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D002478:Cells, Cultured; D016049:Didanosine / Q000008:administration & dosage / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology; D011728:Pyridones / Q000008:administration & dosage / Q000494:pharmacology; D018894:Reverse Transcriptase Inhibitors; D014779:Virus Replication / Q000187:drug effects*; D015215:Zidovudine / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D011725:Pyridines; D011728:Pyridones; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine; D016049:Didanosine